Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

Código QR

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

Guardado en:

Detalles Bibliográficos
Autores principales:	Si-Hang Wang, Ya-Gang Zuo
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	bullous pemphigoid dupilumab treatment IL-4 IL-13 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/4da850d5fffc4d758b2104aac24473b3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Vito Di Lernia, et al.
Publicado: (2020)

Bullous pemphigoid induced by Hijama therapy (cupping)
por: Arghavan Azizpour, et al.
Publicado: (2018)

Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020)

Successful induction treatment of bullous pemphigoid using reslizumab: a case report
por: Hyo-In Rhyou, et al.
Publicado: (2021)

Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Anna Rosińska-Więckowicz, et al.
Publicado: (2021)

The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)
por: Andrey A. Martynov, et al.
Publicado: (2021)

Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
por: Michele Fabrazzo, et al.
Publicado: (2021)

Bullous pemphigoid receiving a novel long‐acting dipeptidyl‐peptidase‐4 (DPP‐4) inhibitor omarigliptin in a patient with type 2 diabetes: A case report
por: Hiroshi Kasamatsu, et al.
Publicado: (2021)

Mucous Membrane Pemphigoid-Associated Malignancies. Case Series and a Brief Overview of the Literature
por: Michelangelo La Placa, et al.
Publicado: (2019)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon S, et al.
Publicado: (2017)

Dupilumab side effect in a patient with atopic dermatitis: a case report study
por: Albader SS, et al.
Publicado: (2019)

Profile of tildrakizumab-asmn in the treatment of moderate-to-severe plaque psoriasis: evidence to date
por: Beck KM, et al.
Publicado: (2018)

Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes
por: Brooks GD
Publicado: (2020)

Immune response in atopic dermatitis: main pathogenetic mechanisms and stage-dependent correlations with age in regard to dermatological and non-dermatological systemic processes
por: M. B. Drozhdina, et al.
Publicado: (2021)

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
por: Yuliya Lytvyn, PhD, et al.
Publicado: (2022)

DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS
por: D. Yu. Trofimov, et al.
Publicado: (2014)

A case of eosinophilic otitis media successfully treated by tympanoplasty with use of dupilumab
por: Saori Kikuchi, et al.
Publicado: (2021)

The Effect of Homocysteine on the Secretion of Il-1β, Il-6, Il-10, Il-12 and RANTES by Peripheral Blood Mononuclear Cells—An In Vitro Study
por: Magdalena Borowska, et al.
Publicado: (2021)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
por: Nicole Edmonds, BA, et al.
Publicado: (2022)

CONTENTS OF CYTOKINES IN BLOOD OF THE PATIENTS WITH LOCAL FROSTBITES
por: K. G. Shapovalov, et al.
Publicado: (2014)

Staphylococcal Scalded Skin Syndrome and Bullous Impetigo
por: Morgan Brazel, et al.
Publicado: (2021)

FEATURES OF IMMUNE DISTURBANCES IN COMMUNITY-ACQUIRED PNEUMONIAS
por: G. A. Mavziutova, et al.
Publicado: (2014)

Keratosis pilaris caused by dupilumab for the treatment of bronchial asthma
por: Yuka Shibata, et al.
Publicado: (2021)

Interleukin (IL)-35 is raising our expectations
por: NING-WEI,ZHAO
Publicado: (2010)

CHARACTERISTICS OF LOCAL INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEPENDENCE ON SEVERITY STAGE
por: L. Yu. Dolinina, et al.
Publicado: (2014)

Efficacy of Dupilumab for Atopic Dermatitis According to Clinical Course and Clinical Findings: A Multicentre Retrospective Study
por: Takeshi Nakahara, et al.
Publicado: (2021)

BP180/Collagen XVII: A Molecular View
por: Jussi Tuusa, et al.
Publicado: (2021)

Bullous systemic lupus erythematosus: exceptional and challenging presentation
por: Salem Bouomrani, et al.
Publicado: (2020)

PROMOTOR POLYMORPHISM OF IL-4, IL-6, AND IL-10 GENES AMONG PATIENTS WITH BREAST CANCER
por: A. V. Shevchenko, et al.
Publicado: (2014)

PROGNOSIS FOR PREDISPOSAL TO DEVELOPMENT OF VIRAL HEPATITIS C BASED ON G-308A TNFА, T-330G IL-2, С-590Т IL-4, С-703Т IL-5, AND C-592A IL-10 GENE POLYMORPHISMS
por: V. V. Avdoshina, et al.
Publicado: (2014)

SPECIFIC STAGE-DEPENDENT FEATURES OF CYTOKINE CASCADE IN THE PATIENTS WITH BRONCHIAL ASTHMA
por: L. V. Ryabova, et al.
Publicado: (2014)

Oral Pemphigoid Recalcitrant Lesion Treated with PRGF Infiltration. Case Report
por: Eduardo Anitua, et al.
Publicado: (2021)

Modern features of VATS treatment of spontaneous pneumothorax as a complication of bullous lung emphysema: a systematic literature review
por: V. A. Toktokhoyev, et al.
Publicado: (2016)

Bullous Aplasia Cutis Congenita—Description of a Novel Dermoscopic Feature
por: Aradhana Rout, et al.
Publicado: (2021)

INVESTIGATION OF CYTOKINE PROFILE IN PATIENTS WITH REACTIVE ARTHRITIS
por: T. V. Gaponova, et al.
Publicado: (2014)

Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies
por: Zengzheng Li, et al.
Publicado: (2021)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
por: M. V. Smolnikova, et al.
Publicado: (2020)

Biologic Treatments of Psoriasis: An Update for the Clinician
por: Brownstone ND, et al.
Publicado: (2021)

AUTOANTIBODIES AND CYTOKINE PROFILE IN PATIENTS WITH GRAVES–BASEDOW DISEASE AND THEIR DYNAMICS DURING THIONAMIDE THERAPY
por: E. V. Markelova, et al.
Publicado: (2014)

Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
por: Fariselli C, et al.
Publicado: (2018)